|
CA2789200C
(en)
*
|
2010-03-22 |
2020-05-26 |
Lead Discovery Center Gmbh |
Pharmaceutically active disubstituted triazine derivatives
|
|
EP2527332A1
(en)
|
2011-05-24 |
2012-11-28 |
Bayer Intellectual Property GmbH |
4-Aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group as CDK9 inhibitors
|
|
TW201636330A
(zh)
|
2011-05-24 |
2016-10-16 |
拜耳知識產權公司 |
含有硫醯亞胺基團之４－芳基－ｎ－苯基－１，３，５－三氮雜苯－２－胺
|
|
CN103917527B
(zh)
|
2011-09-16 |
2017-05-31 |
拜耳知识产权有限责任公司 |
二取代的5‑氟‑嘧啶
|
|
CN103930399B
(zh)
|
2011-09-16 |
2016-03-16 |
拜耳知识产权有限责任公司 |
包含亚氨基亚磺酰基的二取代的5-氟嘧啶衍生物
|
|
US8598937B2
(en)
|
2011-10-07 |
2013-12-03 |
Transphorm Inc. |
High power semiconductor electronic components with increased reliability
|
|
US8803246B2
(en)
|
2012-07-16 |
2014-08-12 |
Transphorm Inc. |
Semiconductor electronic components with integrated current limiters
|
|
ES2616441T3
(es)
*
|
2012-10-18 |
2017-06-13 |
Bayer Pharma Aktiengesellschaft |
Derivados de N-(piridin-2-il))pirimidin-4-amina que contienen un grupo sulfona
|
|
HK1209414A1
(en)
|
2012-10-18 |
2016-04-01 |
Bayer Pharma Aktiengesellschaft |
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
|
|
CN105102434A
(zh)
|
2012-10-18 |
2015-11-25 |
拜耳药业股份公司 |
含砜基团的4-(邻)-氟苯基-5-氟嘧啶-2-基胺
|
|
TW201418243A
(zh)
|
2012-11-15 |
2014-05-16 |
Bayer Pharma AG |
含有磺醯亞胺基團之ｎ－（吡啶－２－基）嘧啶－４－胺衍生物
|
|
ME02880B
(me)
|
2012-11-15 |
2018-04-20 |
Bayer Pharma AG |
Derivati 5-fluoro- n- (piridin -2-il}piridi n- 2 - amina koji sadrze sulfoksiminsku grupu
|
|
US9087718B2
(en)
|
2013-03-13 |
2015-07-21 |
Transphorm Inc. |
Enhancement-mode III-nitride devices
|
|
US9245993B2
(en)
|
2013-03-15 |
2016-01-26 |
Transphorm Inc. |
Carbon doping semiconductor devices
|
|
EP3016945B1
(en)
|
2013-07-04 |
2017-05-03 |
Bayer Pharma Aktiengesellschaft |
Sulfoximine substituted 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives and their use as cdk9 kinase inhibitors
|
|
WO2015009514A1
(en)
|
2013-07-19 |
2015-01-22 |
Transphorm Inc. |
Iii-nitride transistor including a p-type depleting layer
|
|
US9856242B2
(en)
|
2014-03-13 |
2018-01-02 |
Bayer Pharma Aktiengesellscaft |
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
|
|
EP3126338B1
(en)
|
2014-04-01 |
2019-09-04 |
Bayer Pharma Aktiengesellschaft |
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine group
|
|
US9963464B2
(en)
|
2014-04-11 |
2018-05-08 |
Bayer Pharma Aktiengesellschaft |
Macrocyclic compounds
|
|
US9543940B2
(en)
|
2014-07-03 |
2017-01-10 |
Transphorm Inc. |
Switching circuits having ferrite beads
|
|
US9318593B2
(en)
|
2014-07-21 |
2016-04-19 |
Transphorm Inc. |
Forming enhancement mode III-nitride devices
|
|
CN107001341B
(zh)
|
2014-10-16 |
2020-08-07 |
拜耳医药股份有限公司 |
含有磺亚胺基的氟化苯并呋喃基-嘧啶衍生物
|
|
CA2964683A1
(en)
|
2014-10-16 |
2016-04-21 |
Bayer Pharma Aktiengesellschaft |
Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfone group
|
|
WO2016150902A1
(en)
|
2015-03-24 |
2016-09-29 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating gastric cancers
|
|
JP2018509440A
(ja)
|
2015-03-24 |
2018-04-05 |
バイエル ファーマ アクチエンゲゼルシャフト |
リンパ腫の治療のための４−（４−フルオロ−２−メトキシフェニル）−ｎ−｛３−［（ｓ−メチルスルホンイミドイル）メチル］フェニル｝−１，３，５−トリアジン−２−アミンの使用
|
|
JP2018509439A
(ja)
|
2015-03-24 |
2018-04-05 |
バイエル ファーマ アクチエンゲゼルシャフト |
多発性骨髄腫を治療するための４−（４−フルオロ−２−メトキシフェニル）−ｎ−｛３−［（ｓ−メチルスルホンイミドイル）メチル］フェニル｝−１，３，５−トリアジン−２−アミンの使用
|
|
TR201909286T4
(tr)
|
2015-06-29 |
2019-07-22 |
Astrazeneca Ab |
CDK9 inhibitörleri olarak polisiklik amid türevleri.
|
|
JP6847099B2
(ja)
|
2015-09-29 |
2021-03-24 |
バイエル ファーマ アクチエンゲゼルシャフト |
新規な大環状スルホンジイミン化合物
|
|
ES2819869T3
(es)
|
2015-10-08 |
2021-04-19 |
Bayer Pharma AG |
Nuevos compuestos macrocíclicos modificados
|
|
WO2017060322A2
(en)
|
2015-10-10 |
2017-04-13 |
Bayer Pharma Aktiengesellschaft |
Ptefb-inhibitor-adc
|
|
JP6888013B2
(ja)
|
2016-01-15 |
2021-06-16 |
トランスフォーム テクノロジー，インコーポレーテッド |
ＡＬ（１−ｘ）Ｓｉ（ｘ）Ｏゲート絶縁体を有するエンハンスメントモードＩＩＩ族窒化物デバイス
|
|
TWI813243B
(zh)
|
2016-05-31 |
2023-08-21 |
美商創世舫科技有限公司 |
包含漸變空乏層的三族氮化物裝置
|
|
EP3601253B1
(en)
|
2017-03-28 |
2021-09-15 |
Bayer Aktiengesellschaft |
Novel ptefb inhibiting macrocyclic compounds
|
|
CA3057891A1
(en)
|
2017-03-28 |
2018-10-04 |
Bayer Aktiengesellschaft |
Novel ptefb inhibiting macrocyclic compounds
|
|
US11701347B2
(en)
|
2018-02-13 |
2023-07-18 |
Bayer Aktiengesellschaft |
Use of 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{4-[(S-methylsulfonimidoyl)methyl]pyridin-2-yl}pyridin-2-amine for treating diffuse large B-cell lymphoma
|